The biokinetic behavior of toluene was modeled in the rat with a physiologically based pharmacokinetic (PB-PK) model. The model was parameterized by using reference physiological parameter values and partition coefficients that were reported earlier from in vitro studies. Biotransformation parameters for toluene, reported from two in vivo and six in vitro studies, were subsequently substituted in the model while keeping all other model parameters constant Simulations of toluene kinetics, based on these eight biotransformation parameter sets, were compared with empirical data reported on toluene uptake in blood and/or brain tissue after inhalation exposure. It was observed that most empirical data on toluene blood concentrations were adequately predicted by the model for almost each of the eight biotransformation parameter sets. It was also observed that differences between model predictions, based on either in vivo-or in Wfro-derived biotransformation parameters, were generally small. It is concluded that the results from most in vitro studies on toluene biotransformation can be applied successfully to predict the kinetics of toluene in vivo. It is also concluded that the brain-blood partition coefficient may be at least as important for the outcome of the model as the biotransformation parameters are. These results support earlier reported findings in the literature on application of in vitro techniques to derive parameters for PB-PK models, c 19% soday of Toxi col ogy
Simulation of Toluene Kinetics in the Rat by a Physiologically Based Pharmacokinetic Model with Application of Biotransformation Parameters Derived Independently in Vitro and in Vivo. DE-JONGH, J., AND BLAAUBOER, B. J. (1996) . Fundam. AppL Toxicol. 32, 260-268.
The biokinetic behavior of toluene was modeled in the rat with a physiologically based pharmacokinetic (PB-PK) model. The model was parameterized by using reference physiological parameter values and partition coefficients that were reported earlier from in vitro studies. Biotransformation parameters for toluene, reported from two in vivo and six in vitro studies, were subsequently substituted in the model while keeping all other model parameters constant Simulations of toluene kinetics, based on these eight biotransformation parameter sets, were compared with empirical data reported on toluene uptake in blood and/or brain tissue after inhalation exposure. It was observed that most empirical data on toluene blood concentrations were adequately predicted by the model for almost each of the eight biotransformation parameter sets. It was also observed that differences between model predictions, based on either in vivo-or in Wfro-derived biotransformation parameters, were generally small. It is concluded that the results from most in vitro studies on toluene biotransformation can be applied successfully to predict the kinetics of toluene in vivo. It is also concluded that the brain-blood partition coefficient may be at least as important for the outcome of the model as the biotransformation parameters are. These results support earlier reported findings in the literature on application of in vitro techniques to derive parameters for PB-PK models, c 19% soday of Toxi col ogy Toluene is a volatile organic compound that has found a variety of industrial applications. Human exposure to such compounds is usually in the form of inhalation in occupational settings, although for toluene deliberate autoexposure (inhalant abuse) has also been reported (Fornazzari et al., 1983) . Both acute and chronic neurotoxic effects have been observed as a result of exposure to this compound (Benignus, 1981; Rosenberg et al., 1988; WHO, 1985) . The central nervous system (CNS) is considered to be the relevant target tissue in this aspect. In general, the absorption, distribution, metabolism, and excretion (i.e., biokinetics) of xenobiotics form a critical factor in the determination of the site and degree of their toxicity in the organism. Traditionally, in vivo studies have been used to study the biokinetic behavior of xenobiotics. The results of these studies can be interpreted by fitting the collected data to either "classical" compartmental-based kinetic models or the incorporation of data into models that are biologically more realistic, like the physiologically based pharmacokinetic (PB-PK) models (Andersen, 1991; Yang and Andersen, 1994) . Because of the superiority of PB-PK models with respect to extrapolation beyond the observed dose range, dose route, and species, the application of these models for evaluation of the biokinetic aspects of xenobiotics has substantially increased during the last decade (Leung, 1991; Krishnan and Andersen, 1994) . This development has been facilitated by the increasing availability of computer techniques for numerical solution of the differential equations that characterize a PB-PK model . Simultaneous with the advances made in the field of biokinetic model development, both ethical and economical considerations have posed the question whether in vitro techniques may serve as an alternative for the in vivo methods that have generally been used to generate the data required for the construction of these models (Clewell, 1993; Johanson, 1993) . Although many models for the biokinetic behavior of volatile organics do now rely on the in vitro determination of partition coefficients by the vial equilibration technique (Sato and Nakajima, 1979a; Gargas et al., 1989) , only a limited number of models have made use of biotransformation parameters derived from in vitro systems (Gearheart et al., 1990; Kedderis et al., 1993) . Information on the biotransformation of a compound is usually incorporated into a PB-PK model in the form of the Michaelis-Menten parameters V^ and K m . For the determination of these parameters several in vitro techniques, ranging from the application of isolated perfused organs to microsomal incubation, have become available. For toluene, many values for V^ and K m , derived both in vitro and in vivo, have been reported in the literature. In addition, empirical data on uptake and elimination of toluene in vivo have been reported from several studies. Although Table 1. both "classical" and physiologically based descriptions of toluene biokinetics have been reported (Purcell et al, 1990; TardifeVa/., 1993; Gospe et al, 1994; Benignus et al, 1981 Benignus et al, , 1984 , no comprehensive evaluation of the available data on toluene kinetics has been attempted.
The specific aims of this study were (1) to evaluate whether the values for V^ and K m , reported in the literature for toluene from various in vitro studies, may be used to simulate toluene kinetics in vivo, and (2) to determine possible differences in model output resulting from application of either in vitro-or in v/voderived biotransformation parameters.
METHODS

Pharmacokinetic model
The model used in this study is a five-compartment model for the rat (Fig. 1) that is similar to the four-compartment model for styrene (Ramsey and Andersen, 1984) . The five compartments defined for the present model include (1) the liver, serving as the metabolizing organ; (2) fat; (3) a lumped compartment representing slowly perfused tissues, which consists mainly of muscle tissue; (4) a lumped compartment representing richly perfused tissues; and (5) the brain. The brain was added as a separate tissue compartment since the CNS is considered the primary target site for the expression of toluene neurotoxicity.
Toluene was assumed to be eliminated either by exhalation or through saturable biotransformation in the liver (Chapman et al., 1990; WHO, 1985) . V m and K m values were assigned for hepatic metabolism for all simulations.
Values for the physiological parameters were obtained from the literature (Arms and Travis, 1988) and are given in Table 1 . Partition coefficients of toluene were also obtained from the literature (Gargas et al., 1989) . The toluene brain-blood partition coefficent (PBr) was not available for the rat. An estimation was made by dividing the reported brain-air partition coefficient for human brain tissue (Fiserova-Bergerova and Diaz, 1986) with the blood-air partition coefficient for rat tissue (Gargas et al., 1989) . The relative adipose tissue mass (VFQ of rats was estimated as a function of body weight using the following relationships (Bailey et al., 1980; Banks et al., 1990; Anderson et al., 1993) : where VFC = relative adipose tissue mass (fraction of BW) and BW = body weight (g) in (la) Sprague-Dawley, Wistar, and Long-Evans rats and (lb) Fisher 344 rats. To account for differences in other model parameters due to varying body weights the following allometric equations were used (Purcell et al., 1990) :
This way, alveolar ventilation rate (QPC, liters/hr*kg), cardiac output (QCC, liters/hr*kg), and maximum rate of metabolism (V^C, mg/hr*kg) were scaled to whole-animal body weight for each simulation. Thus, the alveolar ventilation (QP) and cardiac output (QC) per animal are expressed in liters/hr and V^ in mg/hr. When comparing the results from different studies, V^C values were used to correct for differences in body weight. All other model parameters, except for V amx C and K m , were held constant during model exercises unless otherwise noted.
The differential equations used to describe the model have been described before (Ramsey and Andersen, 1984) . These equations were numerically integrated using the Advanced Continuous Simulation Language (ACSL, Version 10.1) developed by Mitchell and Gauthier Associates (Concord, MA). This software was running on a 50-Mhz 486DX2 personal computer under the MS-Windows operating system (Version 3.1).
Sources of experimental data for V mmz C and K^ Two in vivo-and six in viVro-derived sets of biotransformation parameters were calculated from data published in the literature and are presented in Table 2 .
Sources of empirical data for toluene blood and brain levels. Benignus et al. (1984) performed an inhalation study with male Long-Evans rats (mean BW, 378 g). Animals were exposed to concentrations of 50, 100, 500, and 1000 ppm for 3 hr. Toluene levels in venous blood and whole brain were determined immediately after exposure. Freundt et al. (1989) performed a similar inhalation experiment with female Sprague-Dawley rats (mean BW, 210 g) exposed to concentrations of 140, 230, 420, and 690 ppm for 2 hr. Venous blood levels of toluene were measured directly after exposure. Benignus et al. (1981) performed an inhalation study with male LongEvans rats (mean BW, 388 g) exposed to a single concentration of 575 ppm toluene for 4 hr. Toluene levels were determined in venous blood and whole brain during exposure and up to 4 hr postexposure. Gospe and Al-Bayati (1994) performed an inhalation study in which male Fisher 344 rats (mean BW, 238 g) were exposed nose-only to H C-labeled toluene for 3 hr at concentrations of 99,549, and 1145 ppm. 14 C radioactivity was determined in the blood of the animals 0.25, 0.5, 1, 2, and 3 hr after the start of the exposure and 0.25,0.5, 1,2, and 4 hr postexposure. According to Reference values (Arms and Travis, 1988) . h Calculated as a function of body weight according to equations lab. ' Measured in vitro (Gargas et al., 1989) . ''Estimated from reported values on the human brain-air partition coefficient (Fiserova-Bergerova and Diaz, 1986 ) and the rat blood-air partition coefficient (Gargas et al, 1989) . Tardif et al, 1993 (b) Purcell et al, 1990 (c) Nakajima and Sato, 1979 (d) Sato and Nakajima, 1979b (e) Nakajima, 1979c (0 Wallen et al, 1985 (g) ' Determined by gas uptake (Gargas et al, 1986) . 'Determined by vial equilibration using supernatant from a I0,000g liver homogenate (Sato and Nakajima, 1979b) . assuming a liver size of 40 g/kg BW.
' Determined by in situ perfusion of the whole liver 1 Determined by a modified vial equilibration technique. V™ extrapolated to the whole rat assuming a liver size of 40 g/kg BW. ' Determined by measuring metabolite appearance after microsomal incubation and assuming benzyl alcohol to be the major metabolite. to the whole rat using a microsomal content of 21.5 mg/g liver and a liver size of 40 g/kg BW. determinations reported in this study, U C radioactivity in blood could be attributed exclusively to parent compound. Kishi et al. (1988) exposed male Wistar rats (mean BW, 400 g) to 125, 250, 500, 1000, 2000, and 4000 ppm of toluene for 4 hr. Blood and brain concentrations of toluene were measured 0.67, 2, and 3 hr after the start of exposure and 0.33, 1, 2, and 3 hr postexposure. Tardif et al. (1992) performed a study in which male Sprague-Dawley rats (mean BW, 263 g) were exposed to 75, 150, or 225 ppm toluene for 5 hr. Toluene blood concentrations were determined 5, 30, and 60 min postexposure. Â nalysis of results. For all simulations, log likelihood (LLK) values of simulated and empirical data were calculated. The LLK is based on a -190 -193 -205 -188 -188 -278 -212 -267 -417 For each column corresponding to a series of simulations, LLK values closest to zero are in boldface to indicate the best agreement between simulated and empirical data.
weighted sum of the squared differences between simulated and empirical data and can be used to classify the results of PB-PK model simulations (Bois et al 1991) . The closer the LLK value is to zero, the better the agreement between simulated and empirical data.
RESULTS
Biotransformation Parameters
From the data on toluene biotransformation parameters in vitro and in vivo (Table 2) it is observed that for seven of eight studies, V^C and K m values differ maximally threeto fourfold. For these seven studies, this results in values for intrinsic clearance at nonsaturating conditions (V^C/ K m ) that vary approximately fivefold. The data from Wang and Nakajima (1991) are clearly out of the general range of miuC and K m values reported in all other studies.
Model Simulations of Empirical Blood Data
Empirical toluene blood data from all six studies are combined and plotted against simulated values based on each of the eight biotransformation parameter sets (Figs. 2a-2h) . The sensitivity of the simulations toward biotransformation is illustrated by results from a simulated scenario where VmmxC equals zero (Fig. 2i) .
Log likelihood values for each single simulation, including overall values for combined empirical data, are presented in Table 3 . Thus, the biotransformation parameter sets corresponding to the most accurate description of each of the six empirical data sets as well as of the combined empirical data are identified by the LLK value closest to zero.
Simulations of the toluene blood levels of the six empirical data sets, each based on its ' 'best'' biotransformtion parameter set (Table 3) (Table 1) for physiological parameters and partition coefficients were used in all simulations unless otherwise noted. Figure 3a shows the blood concentration of toluene after a 3-hr inhalation period as a function of exposure concentration (Benignus et ai, 1984) . Simulations are in good agreement with empirical data and nonlinear kinetic behavior is adequately reflected. In v/vo-derived biotransformation parameters of Purcell et al. (1990) give the most accurate description of this specific data set. Figure 3b shows simulated and empirical blood concentrations after a 2-hr inhalation exposure (Freundt et al., 1989) . All simulations, including the most accurate description based on the in Wfro-derived biotransformation parameters of Nakajima and Sato (1979) , underestimated toluene blood concentrations for the higher exposure concentrations. Figure 3c shows simulated and empirical toluene concentrations in blood during and after a 4-hr exposure to 575 ppm (Benignus etai., 1981) . The in v/vo-derived biotransformation parameters of Purcell et al. (1990) resulted in the most accurate simulation of empirical data. Figure 3d shows simulated toluene concentrations and empirical I4 C radioactivity levels in blood, during and after 3-hr inhalation exposures to 99, 549, and 1145 ppm 14 C-labeled toluene (Gospe and Al-Bayati, 1994) . A best description was given by the biotransformation parameters of Wang and Nakajima (1991) ; however, all simulations of this specific data set were found to be inadequate since systematical under-and overprediction of the data was observed, depending on exposure concentration.
Simulated and empirical toluene blood concentrations during and after 4-hr inhalation exposure to six different concentrations are shown in Fig. 3e (Kishi et al., 1988) . The in Brain concentrations of toluene in male rats, during and/or after inhalation exposure to toluene. Experimental data (means ± SD) from (a) Benignus et al. 1984; Benignus et al., 1981; Kishi et al. 1988 . Lines represent simulations based on biotransformation parameters from (a.b) Purcell et al.. 1990, and (c) Sato and Nakajima, 1979c. v/'/z-o-derived biotransformation data of Sato and Nakajima (1979c) give a best description here.
Simulated and empirical toluene concentrations after a 5-hr inhalation exposure to 75, 150, and 225 ppm are shown in Fig. 3f (Tardif et al., 1992) . Empirical data for the lowest and highest exposure concentrations could not be simulated adequately by any of the eight biotransformation parameters sets: however, a best description was achieved using the parameters of Sato and Nakajima (1979b) .
Model Simulations of Empirical Brain Data
Simulation of toluene brain levels, corresponding to the simulations of toluene blood levels depicted in Figs. 4a-c. show that brain concentrations of toluene after inhalation exposure are systematically overpredicted based on a value of 2 for the brain-blood partition coefficient (PBr) estimated a priori. Values of respectively 1.2, 1.6, and 1.2 were found to give the best agreement between simulated and empirical data (results not shown).
DISCUSSION
Considering the differences in experimental design and the variations in both sex and strain of the animals deployed, the values for V^C and K m are fairly consistent among the different toluene biotransformation studies presented in Table 2 . The data reported by Wang and Nakajima (1991) form the only exception to this observation. A possible explanation for the deviating V^C and K m values reported in this study may be found in the specific method employed for assessing toluene metabolism. In contrast to four of the five other studies, microsomes rather than freshly prepared liver homogenate were used in this specific study.
When comparing simulated venous blood concentrations with empirical data, it can be concluded that use of two in v/vo-derived parameter sets does not lead to substantially better predictions of empirical data than use of in vitroderived biotransformation parameters. The differences that are observed are dependent on both empirical data of the in vivo study and the biotransformation parameters under consideration. As judged by LLK values (Table 3) , only the empirical blood levels from Benignus et al. (1981 Benignus et al. ( , 1984 are best described by simulations using in v/'vo-derived biotransformation parameters from Purcell et al. (1990) . For simulations corresponding to empirical data in Figs. 3a-c and e, application of the eight biotransformation sets from Table 2 results in marginal differences between respective simulations, and adequate descriptions of the corresponding empirical data are generally observed. In contrast, the empirical data from Gospe and Al-Bayati (1994) and, to a lesser degree, Tardif et al. (1993) in Figs. 3d and f are not very well described by any simulation based on one of the eight sets of biotransformation parameters. The experimental design of the study by Gospe and Al-Bayati was unique in the fact that radiolabeled material was used and that rats were exposed nose-only; however, evidence for the fact that radioactivity represents unmetabolized toluene only is presented in this study. The difference between nose-only exposure and whole-body exposure is not expected to have a substantial influence on the results, as an earlier study reported that dermal uptake of toluene vapor is less than 4% of total uptake (McDougal et al., 1990) . Thus, the reason for the difference between this specific study and the other four studies is presently not clear.
The best description of empirical data combined from all six considered studies (Table 3 and Figs. 2a-h ) is given by simulations based on biotransformation parameters from Sato and Nakajima (1979c) . Differences between this specific biotransformation parameter set and the three other in v/7ro-derived sets, which are all based on the same vial equilibration method, are, however, small. Biotransformation data derived from vial equilibration studies, all using freshly isolated liver homogenates, seem to be superior to the data from the other two in vitro studies.
The apparent misspecification of the a priori estimated value for the brain-blood partition coefficient (PBr = 2, Figs. 4a-c) may be attributed to the fact that results from both rat and human studies had to be combined to derive this value.
In summary, it is concluded that the kinetic behavior of toluene, a volatile compound that is rapidly metabolized, may be successfully simulated on the basis of in vitro-derived model parameters. These findings are in accordance with previously reported results on simulation of benzene metabolism (DeJongh and Blaauboer, 1995) . Additional studies, including nonvolatile compounds, should be performed to evaluate the full potential of in vitro techniques for simulating the kinetic behavior of xenobiotics. It can be expected that this may eventually lead to a reduction in the number of laboratory animals deployed in biokinetic studies.
